Targeted Cancer Therapies World Congress 2010
September 21 - 23, 2010
チューリッヒ , スイス
span style="font-weight: bold;">The World’s first strategic event to address critical issues in bringing targeted therapies for cancer from early development into the market.
Key representation from Roche, Novartis, Biogen Idec, ImClone Systems, Merck Serono, Merck & Co, Abbott Laboratories, Pfizer, AstraZeneca, Human Genome Sciences, Bayer, Sanofi Aventis and many more.... Join them register now!
Taking aim - the oncology market looks to the nex generation of targeted cancer therapies.The Targeted Cancer Therapy World Congress 2010 is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.
Key representation from Roche, Novartis, Biogen Idec, ImClone Systems, Merck Serono, Merck & Co, Abbott Laboratories, Pfizer, AstraZeneca, Human Genome Sciences, Bayer, Sanofi Aventis and many more.... Join them register now!
Taking aim - the oncology market looks to the nex generation of targeted cancer therapies.The Targeted Cancer Therapy World Congress 2010 is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.
関連イベント
Targeted Cancer Therapies World Congress September 21 - 23, 2010
